FIGO 2009 World Congress of Gynecology and Obstetrics

Gynuity sponsored and organized three panels on medical abortion, misoprostol for pregnancy failure, and misoprostol for postpartum hemorrhage.

Gynuity Health Projects – Misoprostol for Postpartum Haemorrhage: New Evidence-Based Science for Safe Motherhood

Chair: Beverly Winikoff, USA

• Beverly Winikoff, USA – “Misoprostol for PPH: From Research to Reality”
• Jill Durocher, USA – “Understanding PPH: Its Frequency and Treatment”
• Nadeem Zuberi, Pakistan – “Misoprostol for Prevention of PPH: Evidence from an RCT of Homebirths in Northern Pakistan”
• Nhu Ngoc thi Nguyen, Vietnam – “An RCT of Misoprostol Versus Oxytocin for Treatment of PPH in Women Not Given Prophylactic Oxytocin”
• Berna Dilbaz, Turkey – “An RCT of Misoprostol Versus Oxytocin for Treatment of PPH in Women Given Prophylactic Oxytocin”
• Jennifer Blum, USA – “Putting it All Together: What Does This Mean for Saving Women’s Lives”

Gynuity Health Projects – Misoprostol for Pregnancy Failure: Research Results and Programme Update

Chair: Beverly Winkoff, USA

• Jennifer Blum, USA – “Misoprostol for Pregnancy Failure: A Summary of Progress – from Research to Reality”
• Ayisha Diop, USA – “Misoprostol as First Line Treatment of Incomplete Abortion: Evidence from Sub-Saharan Africa”
• Mohamed Ramadan, Egypt – “Misoprostol Versus MVA for Incomplete Abortion: Results from a Randomized Controlled Trial in Egypt”
• Wilfrido Leon, Ecuador – “Introduction of Misoprostol for Incomplete Abortion Care in Latin America: Evidence from Ecuador”

IPAS, International Consortium for Medical Abortion, and Gynuity Health Projects: Reaching Women with Medical Abortion Services

Chair: Eunice Brookman-Amissah, Kenya

• Leonel Briozzo, Uruguay – “An Innovative Model for Risk Reduction in Uruguay”
• Rashmi Singh, India – “Community Outreach to Improve Medical Abortion Access in India”
• Sudha Sharma, Nepal – “Introducing Medical Abortion at the Community Level in Nepal”
• Patricio Sanhueza, Mexico – “Introducing Medical Abortion in the Public Sector in Mexico City”

During the conference Gynuity staff and international colleagues delivered several presentations on the following maternal and reproductive health issues derived from the research projects conducted by Gynuity.

Preeclampsia

• Annie Regi, India – “Magnesium Sulfate for PreEclampsia: A Study of Attitudes and Barriers in India”
• Shuchita Mundle, India – “Preeclampsia in Low-resource Settings: A Randomized Trial of IV Mgso4 via Flow Controlled Pump”

Postpartum hemorrhage

• Gustavo Barrera, Ecuador – “Side Effects Following Misoprostol Administration for Treatment of Primary Postpartum Hemorrhage in Quito, Ecuador”
• Serdar Yalvac , Turkey – “The Effect of Active Management on Postpartum Blood Loss in a Turkish Maternity” (poster presentation)
• Blami Dao, Burkina Faso – “Side Effect Profiles For Misoprostol And Oxytocin In The Treatment Of Postpartum Hemorrhage”
• Kurus J. Coyaji , India – “A Comparison of Drape Estimation and A Standardized Weight Method for the Measurement of Postpartum Blood Loss”

Misoprostol for pregnancy loss

• Beverly Winikoff, USA – “Pregnancy Loss”
• Emad Darwish, Egypt – “Bleeding Following Surgical (MVA) And Medical (400 µg Sublingual Misoprostol) Treatment Of Incomplete Abortion”

Medical abortion

• Jennifer Blum, USA – “Medical Abortion With Misoprostol Only Versus Mifepristone Plus Misoprostol: Results From A Randomized Controlled Trial”
• Hillary Bracken, USA – “Alternatives To Routine Ultrasound For Eligibility Assessment Prior To Early Medical Abortion”
• Hillary Bracken, USA – “Alternatives to a Routine Follow-Up Visit For Early Medical Abortion”
• Hela Chelli, Tunisia – “A Randomized Controlled Study Of Sublingual vs. Oral Misoprostol (400 µg) Following Mifepristone (200 Mg) For Medical Abortion Up To 63 Days L.M.P. In Tunisia”

• Rodica Comendant, Moldova – “Two-Pill Regimens Of Misoprostol After Mifepristone Medical Abortion Through 63 Days’ LMP: A Randomized Controlled Trial Of Buccal And Sublingual Misoprostol”
• Kelsey Lynd, USA – “Preliminary Results Of The Semi-Quantitative Pregnancy Test And Its Impact On Reproductive Health Service Provision”
• Nguyen Thi Nhu Ngoc, Vietnam – “Mifepristone And Misoprostol Versus Misoprostol Alone For Mid-Trimester Termination Of Pregnancy (14 – 21 Weeks LMP): A Randomized-Controlled Double-Blinded Trial”
• Joseph Taylor, Ghana – “Increasing Access To Safe Abortion Through The Introduction Of Medical Abortion In Ghana: Results From A Clinical Study Offering Medical Abortion To Women In Ghana”